AEON Biopharma, Inc. Accounts Payable
AEON Biopharma, Inc. (AEON) had Accounts Payable of $2.70 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-12
- 2026-06-30: Accounts Payable, Current $2.70M.
- 2026-03-31: Accounts Payable, Current $1.48M.
- 2025-12-31: Accounts Payable, Current $942.00K.
- 2025-09-30: Accounts Payable, Current $2.52M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $2.70M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $1.48M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $942.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $2.52M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $3.91M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $2.44M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $5.91M 10-K · filed 2026-03-30 |
| 2024-09-30 | $4.63M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $3.03M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $6.52M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $3.39M 10-K · filed 2025-03-24 |
| 2023-09-30 | $4.01M 10-Q/A · filed 2024-03-29 |
| 2022-12-31 | $7.80M 10-K/A · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |